Wiktoria Wrobel

Mrs. Wiktoria Wrobel

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
WWWiktoria Wrobel
Wiktoria Wrobel
EPEmilia Pach
Emilia Pach
IBIwonaBen-Skowronek Ben-Skowronek
IwonaBen-Skowronek Ben-Skowronek
Achondroplasia (ACH) is a disease caused by a missense mutation in the FGFR3 (fibroblast growth factor receptor 3) gene, which is the most common cause of short stature in humans. The treatment of ACH is necessary and urgent because untreated achondroplasia has many complications, both orthopedic and neurological, which ultimately lead to disability. This review presents the current and potential pharmacological treatments for achondroplasia, highlighting the advantages and disadvantages of all the drugs that have been demonstrated in human and animal studies in different stages of clinical trials. The article includes the potential impacts of drugs on achondroplasia symptoms other than short stature, including their effects on spinal canal stenosis, the narrowing of the foramen magnum and the proportionality of body structure. Addressing these effects could significantly improve the quality of life of patients, possibly reducing the frequency and necessity of hospitalization and painful surgical procedures, which are currently the only therapeutic options used. The criteria for a good drug for achondroplasia are best met by recombinant human growth hormone at present and will potentially be met by vosoritide in the future, while the rest of the drugs are in the early stages of clinical trials.

Verified
Journal Article
Open access
PDF file
IBIwonaBen-Skowronek Ben-Skowronek
IwonaBen-Skowronek Ben-Skowronek
JSJoanna Sieniawska
Joanna Sieniawska
EPEmilia Pach
Emilia Pach
WWWiktoria Wrobel
Wiktoria Wrobel
ASAnna Skowronek
Anna Skowronek
IRIga Rosolowska
Iga Rosolowska
The autoimmune reaction against the beta cells of the pancreatic islets in type 1 diabetes mellitus (T1DM) patients is active in prediabetes and during the development of the clinical manifestation of T1DM, but it decreases within a few years of the clinical manifestation of this disease. A key role in the pathogenesis of T1DM is played by regulatory T cell (Treg) deficiency or dysfunction. Immune interventions, such as potential therapeutic applications or the induction of the Treg-cell population in T1DM, will be important in the development of new types of treatment. The aim of this study was to evaluate innovative immune interventions as treatments for T1DM. After an evaluation of full-length papers from the PubMed database from 2010 to 2021, 20 trials were included for the final analysis. The analysis led to the following conclusions: Treg cells play an important role in the limitation of the development of T1DM, the activation or application of Tregs may be more effective in the early stages of T1DM development, and the therapeutic use of Treg cells in T1DM is promising but requires long-term observation in a large group of patients.

28 September 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IBIwonaBen-Skowronek Ben-Skowronek
IwonaBen-Skowronek Ben-Skowronek
JSJoanna Sieniawska
Joanna Sieniawska
EPEmilia Pach
Emilia Pach
WWWiktoria Wrobel
Wiktoria Wrobel
ASAnna Skowronek
Anna Skowronek
PNPawel Nachulewicz
Pawel Nachulewicz
Thyroid nodules are common in the adult population (13%), but in childhood, they are relatively rarely diagnosed (0.2–5%). The risk factors and diagnostic and therapeutic algorithms are well-known and effectively used in adults, but no clear procedures supported by scientific research are available in the pediatric population. Our aim in this study was to identify predictive factors for thyroid cancer in a pediatric population. We retrospectively analyzed 112 children (80 girls and 32 boys, aged 0.6–18 years, with an average group age of 13.4 ± 4.5 years) with thyroid nodules who presented or were referred between 2010 and 2021. A total of 37 children qualified for partial or total thyroidectomy. After histopathological nodule examination, the most common cases were benign lesions in 23 patients (57.5%) and malignant lesions in 14 children (32.5%). Solitary benign thyroid nodules were found in 16 children (40%). Malignancy risk was higher in children with increased nodule diameter (greater than 7 mm; p = 0.018) or hypoechogenic lesions in ultrasound (p = 0.010), with no correlation between increased blood flow in the vessels and tumor diagnosis. The relative risk of developing thyroid cancer for class III was found to be higher in comparison to adults and 11.1 times higher than for classes I and II combined.

1 September 2024 in Translational Pediatrics
Verified
Journal Article
Open access
PDF file
WWWiktoria Wrobel
Wiktoria Wrobel
IBIwonaBen-Skowronek Ben-Skowronek
IwonaBen-Skowronek Ben-Skowronek
Assessment of the efficacy of vosoritide therapy in children with achondroplasia in clinical trials